Stopping psychotropic drugs? Why, when and how?

My new book in German is now available: “Psychopharmaka absetzen? Warum, wann und wie?” (English “Stopping psychotropic drugs? Why, when and how?). The book is not a simple invitation to stop taking psychotropic drugs, but a critical examination of the topic.

An Interview on the Foundations of Psychiatry

An interview for DasGehirn.Info on our understanding of psychopharmacology and its further development, about humanism and the political responsibility of psychiatry.

A Lecture on News in Psychopharmacology

My lecture on “Hot Topic: Psychopharmaka”, held in Mainz on March 15th, 2019, as part of the teaching event “Psychiatrie Update 2019”, was videotaped.

Interviews on Esketamine, Depression and the Wish to have Children

A brief post on some interviews I gave recently on esketamine for treatment-resistant depression and depression in women who have problems getting pregnant.

FDA Approves Esketamine for Treatment-Resistant Depression, While US Suicide Rate Reaches Record High

The US FDA approved esketamine nasal spray on March 5th, 2019, while deaths from synthetic opioids and suicides hit a record high in 2017.

How Common are Withdrawal and Emotional Blunting in Chronic Antidepressant Treatment?

The problem of withdrawal syndromes and emotional blunting occurring with prolonged antidepressant treatment is constantly underestimated by clinicians.

The Antidepressant Debate in the New York Times

An article on the front page of the New York Times on April 7, 2018, has fueled the debate over antidepressants again.

How effective are antidepressants?

Andrea Cipriani from the University of Oxford and colleagues have recently published the largest and most comprehensive meta-analysis of the efficacy of antidepressants in the Lancet. The paper is worth dealing with more intensively.